{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T14:13:58Z","timestamp":1790172838351,"version":"4.1.0"},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T00:00:00Z","timestamp":1583452800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Musculoskelet Disord"],"published-print":{"date-parts":[[2020,12]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Rheumatoid arthritis is a long-term, progressive autoimmune disease. It is characterized by synovial hyperplasia leading to swelling, stiffness, and joint deformity in more than one joint. Fibroblast-like synoviocytes are the major cell types that make up the synovial intima structure, which is one of the decisive factors in the development and course of rheumatoid arthritis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>The potential therapeutic effects of MSCs-derived miRNA-124a overexpression exosomes were evaluated in vitro by the method including MTT assay and cell cycle test for cell proliferation, scratch wound closure and transwell for cell migration, flow cytometry and western for the apoptosis detection.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Exosomes derived from human MSCs that overexpression miRNA-124a were prepared and characterized. We found that the pretreatment of this exosome was able to inhibit the proliferation and migration of fibroblast-like synoviocyte cell line and promote the apoptosis of this cell during the co-incubation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Exosomes derived from MSCs were proved to be a suitable vector for the delivery of therapeutic miRNA-124a, and such miRNA-124a overexpression exosomes were expected to provide a new medicine and strategy for the treatment of rheumatoid arthritis.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12891-020-3159-y","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T08:02:52Z","timestamp":1583481772000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":78,"title":["The inhibition by human MSCs-derived miRNA-124a overexpression exosomes in the proliferation and migration of rheumatoid arthritis-related fibroblast-like synoviocyte cell"],"prefix":"10.1186","volume":"21","author":[{"given":"Hong-Yan","family":"Meng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Qing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Hui","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,3,6]]},"reference":[{"issue":"6937","key":"3159_CR1","doi-asserted-by":"publisher","first-page":"356","DOI":"10.1038\/nature01661","volume":"423","author":"GS Firestein","year":"2003","unstructured":"Firestein GS. Evolving concepts of rheumatoid arthritis. Nature. 2003;423(6937):356.","journal-title":"Nature"},{"issue":"12","key":"3159_CR2","doi-asserted-by":"publisher","first-page":"3613","DOI":"10.1002\/art.25018","volume":"60","author":"E Karouzakis","year":"2009","unstructured":"Karouzakis E, Gay RE, Michel BA, Gay S, Neidhart M. DNA hypomethylation in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum. 2009;60(12):3613\u201322.","journal-title":"Arthritis Rheum"},{"issue":"1","key":"3159_CR3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1111\/j.0105-2896.2009.00859.x","volume":"233","author":"B Bartok","year":"2010","unstructured":"Bartok B, Firestein GS. Fibroblast-like synoviocytes: key effector cells in rheumatoid arthritis. Immunol Rev. 2010;233(1):233\u201355.","journal-title":"Immunol Rev"},{"issue":"7","key":"3159_CR4","doi-asserted-by":"publisher","first-page":"1829","DOI":"10.1007\/s00296-012-2657-0","volume":"33","author":"J Tian","year":"2013","unstructured":"Tian J, Chen J-w, Gao J-s, Li L, Xie X. Resveratrol inhibits TNF-\u03b1-induced IL-1\u03b2, MMP-3 production in human rheumatoid arthritis fibroblast-like synoviocytes via modulation of PI3kinase\/Akt pathway. Rheumatol Int. 2013;33(7):1829\u201335.","journal-title":"Rheumatol Int"},{"issue":"suppl 2","key":"3159_CR5","first-page":"ii28","volume":"63","author":"L Klareskog","year":"2004","unstructured":"Klareskog L, Alfredsson L, Rantap\u00e4\u00e4-Dahlqvist S, Berglin E, Stolt P, Padyukov L. What precedes development of rheumatoid arthritis? Ann Rheum Dis. 2004;63(suppl 2):ii28\u201331.","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"3159_CR6","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1038\/nrm2347","volume":"9","author":"G Stefani","year":"2008","unstructured":"Stefani G, Slack FJ. Small non-coding RNAs in animal development. Nat Rev Mol Cell Biol. 2008;9(3):219.","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"1","key":"3159_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1582-4934.2007.00196.x","volume":"12","author":"B Zhang","year":"2008","unstructured":"Zhang B, Farwell M. MicroRNAs: a new emerging class of players for disease diagnostics and gene therapy. J Cell Mol Med. 2008;12(1):3\u201321.","journal-title":"J Cell Mol Med"},{"issue":"7","key":"3159_CR8","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1038\/nrurol.2013.113","volume":"10","author":"H Yoshino","year":"2013","unstructured":"Yoshino H, Seki N, Itesako T, Chiyomaru T, Nakagawa M, Enokida H. Aberrant expression of microRNAs in bladder cancer. Nat Rev Urol. 2013;10(7):396.","journal-title":"Nat Rev Urol"},{"issue":"6","key":"3159_CR9","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1517\/14712590902932889","volume":"9","author":"MA Cortez","year":"2009","unstructured":"Cortez MA, Calin GA. MicroRNA identification in plasma and serum: a new tool to diagnose and monitor diseases. Expert Opin Biol Ther. 2009;9(6):703\u201311.","journal-title":"Expert Opin Biol Ther"},{"issue":"4","key":"3159_CR10","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1002\/art.23386","volume":"58","author":"J Stanczyk","year":"2008","unstructured":"Stanczyk J, Pedrioli DML, Brentano F, Sanchez-Pernaute O, Kolling C, Gay RE, Detmar M, Gay S, Kyburz D. Altered expression of MicroRNA in synovial fibroblasts and synovial tissue in rheumatoid arthritis. Arthritis Rheum. 2008;58(4):1001\u20139.","journal-title":"Arthritis Rheum"},{"issue":"2","key":"3159_CR11","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1186\/ar4194","volume":"15","author":"X Luo","year":"2013","unstructured":"Luo X, Ranade K, Talker R, Jallal B, Shen N, Yao Y. MicroRNA-mediated regulation of innate immune response in rheumatic diseases. Arthritis Res Ther. 2013;15(2):210.","journal-title":"Arthritis Res Ther"},{"issue":"2","key":"3159_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1002\/art.30115","volume":"63","author":"J Stanczyk","year":"2011","unstructured":"Stanczyk J, Ospelt C, Karouzakis E, Filer A, Raza K, Kolling C, Gay R, Buckley CD, Tak PP, Gay S. Altered expression of microRNA-203 in rheumatoid arthritis synovial fibroblasts and its role in fibroblast activation. Arthritis Rheum. 2011;63(2):373\u201381.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"3159_CR13","first-page":"3972","volume":"17","author":"L Yu","year":"2018","unstructured":"Yu L, Wang S, Lin X, Lu Y, Gu P. MicroRNA-124a inhibits cell proliferation and migration in liver cancer by regulating interleukin-11. Mol Med Rep. 2018;17(3):3972\u20138.","journal-title":"Mol Med Rep"},{"issue":"6","key":"3159_CR14","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1016\/j.ejca.2010.11.026","volume":"47","author":"A Fowler","year":"2011","unstructured":"Fowler A, Thomson D, Giles K, Maleki S, Mreich E, Wheeler H, Leedman P, Biggs M, Cook R, Little N. Mir-124a is frequently down-regulated in glioblastoma and is involved in migration and invasion. Eur J Cancer. 2011;47(6):953\u201363.","journal-title":"Eur J Cancer"},{"issue":"5","key":"3159_CR15","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1002\/art.24475","volume":"60","author":"Y Nakamachi","year":"2009","unstructured":"Nakamachi Y, Kawano S, Takenokuchi M, Nishimura K, Sakai Y, Chin T, Saura R, Kurosaka M, Kumagai S. MicroRNA-124a is a key regulator of proliferation and monocyte chemoattractant protein 1 secretion in fibroblast-like synoviocytes from patients with rheumatoid arthritis. Arthritis Rheum. 2009;60(5):1294\u2013304.","journal-title":"Arthritis Rheum"},{"issue":"8","key":"3159_CR16","doi-asserted-by":"publisher","first-page":"2472","DOI":"10.4049\/jimmunol.1800304","volume":"201","author":"Z Chen","year":"2018","unstructured":"Chen Z, Wang H, Xia Y, Yan F, Lu Y. Therapeutic potential of Mesenchymal cell\u2013derived miRNA-150-5p\u2013expressing Exosomes in rheumatoid arthritis mediated by the modulation of MMP14 and VEGF. J Immunol. 2018;201(8):2472\u201382.","journal-title":"J Immunol"},{"issue":"5","key":"3159_CR17","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1002\/jor.1100090504","volume":"9","author":"AI Caplan","year":"1991","unstructured":"Caplan AI. Mesenchymal stem cells. J Orthop Res. 1991;9(5):641\u201350.","journal-title":"J Orthop Res"},{"issue":"24","key":"3159_CR18","doi-asserted-by":"publisher","first-page":"3192","DOI":"10.1089\/scd.2013.0023","volume":"22","author":"L Wang","year":"2013","unstructured":"Wang L, Wang L, Cong X, Liu G, Zhou J, Bai B, Li Y, Bai W, Li M, Ji H. Human umbilical cord mesenchymal stem cell therapy for patients with active rheumatoid arthritis: safety and efficacy. Stem Cells Dev. 2013;22(24):3192\u2013202.","journal-title":"Stem Cells Dev"},{"issue":"10","key":"3159_CR19","doi-asserted-by":"publisher","first-page":"3837","DOI":"10.1182\/blood-2003-04-1193","volume":"102","author":"F Djouad","year":"2003","unstructured":"Djouad F, Plence P, Bony C, Tropel P, Apparailly F, Sany J, No\u00ebl D, Jorgensen C. Immunosuppressive effect of mesenchymal stem cells favors tumor growth in allogeneic animals. Blood. 2003;102(10):3837\u201344.","journal-title":"Blood"},{"issue":"3","key":"3159_CR20","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.scr.2009.12.003","volume":"4","author":"RC Lai","year":"2010","unstructured":"Lai RC, Arslan F, Lee MM, Sze NSK, Choo A, Chen TS, Salto-Tellez M, Timmers L, Lee CN, El Oakley RM. Exosome secreted by MSC reduces myocardial ischemia\/reperfusion injury. Stem Cell Res. 2010;4(3):214\u201322.","journal-title":"Stem Cell Res"},{"issue":"3","key":"3159_CR21","doi-asserted-by":"publisher","first-page":"153","DOI":"10.31083\/j.rcm.2019.03.528","volume":"20","author":"W Jiang","year":"2019","unstructured":"Jiang W, Wang M. New insights into the immunomodulatory role of exosomes in cardiovascular disease. Rev Cardiovasc Med. 2019;20(3):153\u201360.","journal-title":"Rev Cardiovasc Med"},{"issue":"2","key":"3159_CR22","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3233\/JIN-170052","volume":"17","author":"X Ni","year":"2018","unstructured":"Ni X, Liao Y, Li L, Zhang X, Wu Z. Therapeutic role of long non-coding RNA TCONS_00019174 in depressive disorders is dependent on Wnt\/\u03b2-catenin signaling pathway. J Integr Neurosci. 2018;17(2):203\u201315.","journal-title":"J Integr Neurosci"},{"issue":"3","key":"3159_CR23","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1093\/rheumatology\/kel267","volume":"46","author":"C Bocelli-Tyndall","year":"2006","unstructured":"Bocelli-Tyndall C, Bracci L, Spagnoli G, Braccini A, Bouchenaki M, Ceredig R, Pistoia V, Martin I, Tyndall A. Bone marrow mesenchymal stromal cells (BM-MSCs) from healthy donors and auto-immune disease patients reduce the proliferation of autologous-and allogeneic-stimulated lymphocytes in vitro. Rheumatology. 2006;46(3):403\u20138.","journal-title":"Rheumatology"},{"issue":"5","key":"3159_CR24","doi-asserted-by":"publisher","first-page":"R169","DOI":"10.1186\/ar4355","volume":"15","author":"Z Zhang","year":"2013","unstructured":"Zhang Z, Ding Y, Li W, Song B, Yang R. Interleukin-17A-or tumor necrosis factor \u03b1-mediated increase in proliferation of T cells cocultured with synovium-derived mesenchymal stem cells in rheumatoid arthritis. Arthritis Res Ther. 2013;15(5):R169.","journal-title":"Arthritis Res Ther"},{"key":"3159_CR25","doi-asserted-by":"crossref","unstructured":"Tse W, Pendleton J, Beyer W, Egalka M, Guinan E. Suppression of allogeneic T-cell proliferation by human marrow stromal cells: implications in transplantation, transplantation. 2003.","DOI":"10.1097\/01.TP.0000045055.63901.A9"},{"issue":"1","key":"3159_CR26","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1007\/s10067-011-1816-0","volume":"31","author":"J Liang","year":"2012","unstructured":"Liang J, Li X, Zhang H, Wang D, Feng X, Wang H, Hua B, Liu B, Sun L. Allogeneic mesenchymal stem cells transplantation in patients with refractory RA. Clin Rheumatol. 2012;31(1):157\u201361.","journal-title":"Clin Rheumatol"},{"issue":"5","key":"3159_CR27","doi-asserted-by":"publisher","first-page":"1399","DOI":"10.7150\/thno.21072","volume":"8","author":"S Cosenza","year":"2018","unstructured":"Cosenza S, Toupet K, Maumus M, Luz-Crawford P, Blanc-Brude O, Jorgensen C, No\u00ebl D. Mesenchymal stem cells-derived exosomes are more immunosuppressive than microparticles in inflammatory arthritis. Theranostics. 2018;8(5):1399.","journal-title":"Theranostics"},{"issue":"5","key":"3159_CR28","doi-asserted-by":"publisher","first-page":"467","DOI":"10.3390\/cells8050467","volume":"8","author":"CR Harrell","year":"2019","unstructured":"Harrell CR, Fellabaum C, Jovicic N, Djonov V, Arsenijevic N, Volarevic V. Molecular mechanisms responsible for therapeutic potential of Mesenchymal stem cell-derived Secretome. Cells. 2019;8(5):467.","journal-title":"Cells"},{"issue":"2","key":"3159_CR29","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1111\/2049-632X.12135","volume":"71","author":"A Fleming","year":"2014","unstructured":"Fleming A, Sampey G, Chung MC, Bailey C, Van Hoek ML, Kashanchi F, Hakami RM. The carrying pigeons of the cell: exosomes and their role in infectious diseases caused by human pathogens. Pathog Dis. 2014;71(2):109\u201320.","journal-title":"Pathog Dis"},{"key":"3159_CR30","first-page":"56","volume":"3","author":"G Hu","year":"2012","unstructured":"Hu G, Drescher KM, Chen X. Exosomal miRNAs: biological properties and therapeutic potential. Front Genet. 2012;3:56.","journal-title":"Front Genet"},{"key":"3159_CR31","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.biomaterials.2016.03.025","volume":"91","author":"SH Taj","year":"2016","unstructured":"Taj SH, Kho W, Riou A, Wiedermann D, Hoehn M. MiRNA-124 induces neuroprotection and functional improvement after focal cerebral ischemia. Biomaterials. 2016;91:151\u201365.","journal-title":"Biomaterials"},{"issue":"3","key":"3159_CR32","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.nano.2015.10.011","volume":"12","author":"AM Louw","year":"2016","unstructured":"Louw AM, Kolar MK, Novikova LN, Kingham PJ, Wiberg M, Kjems J, Novikov LN. Chitosan polyplex mediated delivery of miRNA-124 reduces activation of microglial cells in vitro and in rat models of spinal cord injury. Nanomedicine. 2016;12(3):643\u201353.","journal-title":"Nanomedicine"},{"issue":"3","key":"3159_CR33","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1136\/annrheumdis-2014-206417","volume":"75","author":"Y Nakamachi","year":"2016","unstructured":"Nakamachi Y, Ohnuma K, Uto K, Noguchi Y, Saegusa J, Kawano S. MicroRNA-124 inhibits the progression of adjuvant-induced arthritis in rats. Ann Rheum Dis. 2016;75(3):601\u20138.","journal-title":"Ann Rheum Dis"},{"key":"3159_CR34","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1016\/j.intimp.2018.09.049","volume":"65","author":"Y Wang","year":"2018","unstructured":"Wang Y, Dai L, Wu H, Zhang Z-r, Wang W-y, Fu J, Deng R, Li F, Dai X-j, Zhan X. Novel anti-inflammatory target of geniposide: inhibiting Itg\u03b21\/Ras-Erk1\/2 signal pathway via the miRNA-124a in rheumatoid arthritis synovial fibroblasts. Int Immunopharmacol. 2018;65:284\u201394.","journal-title":"Int Immunopharmacol"},{"issue":"3","key":"3159_CR35","doi-asserted-by":"publisher","first-page":"192","DOI":"10.1038\/sc.2009.89","volume":"48","author":"K Nakanishi","year":"2010","unstructured":"Nakanishi K, Nakasa T, Tanaka N, Ishikawa M, Yamada K, Yamasaki K, Kamei N, Izumi B, Adachi N, Miyaki S. Responses of microRNAs 124a and 223 following spinal cord injury in mice. Spinal Cord. 2010;48(3):192.","journal-title":"Spinal Cord"},{"issue":"2","key":"3159_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1016\/j.expneurol.2009.06.015","volume":"219","author":"N-K Liu","year":"2009","unstructured":"Liu N-K, Wang X-F, Lu Q-B, Xu X-M. Altered microRNA expression following traumatic spinal cord injury. Exp Neurol. 2009;219(2):424\u20139.","journal-title":"Exp Neurol"}],"container-title":["BMC Musculoskeletal Disorders"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-3159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12891-020-3159-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12891-020-3159-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,5]],"date-time":"2021-03-05T19:32:12Z","timestamp":1614972732000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcmusculoskeletdisord.biomedcentral.com\/articles\/10.1186\/s12891-020-3159-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,3,6]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["3159"],"URL":"https:\/\/doi.org\/10.1186\/s12891-020-3159-y","relation":{},"ISSN":["1471-2474"],"issn-type":[{"value":"1471-2474","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,3,6]]},"assertion":[{"value":"22 November 2019","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 March 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"150"}}